Technical Considerations and Confounders for Urine CXCL10 Chemokine Measurement

Joëlle Handschin, Patricia Hirt‐Minkowski, Gideon Hönger, Sandra Mitrović, Spasenija Savic Prince, Julie Ho, Peter Nickerson, Stefan Schaub

Transplantation Direct · 2019 · 15 citations · 26 references

DOIFull text

Open access

Abstract

Urine CXCL10 measurement on the used platform is accurate and robust. Leucocyturia and active BK-polyomavirus infection are major confounders, which can be easily detected but represent important diagnostic "blind spots" when using urine CXCL10 to screen for allograft rejection. The intraindividual biological variability of urine CXCL10 within 1-2 weeks is mostly below ±50%, which is still much higher than the technical variability due to sample handling/processing (<20%).

References

26